ATORVASTATIN SANDOZ atorvastatin 40 mg film-coated tablet bottle

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

atorvastatin calcium trihydrate, Quantity: 43.3 mg

Mevcut itibaren:

Sandoz Pty Ltd

Farmasötik formu:

Tablet, film coated

Kompozisyon:

Excipient Ingredients: polysorbate 80; microcrystalline cellulose; magnesium stearate; hyprolose; croscarmellose sodium; lactose monohydrate; calcium carbonate; titanium dioxide; hypromellose; macrogol 6000

Uygulama yolu:

Oral

Paketteki üniteler:

100 (dispensing use only)

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Atorvastatin Sandoz is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia. Prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemia, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated.,Atorvastatin Sandoz is indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD) which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic CHD to reduce the risk of non-fatal myocardial infarction (MI) and non-fatal stroke.,These effects do not replace the need to independently control known causes of cardiovascular (CV) mortality and morbidity such as hypertension, diabetes and smoking

Ürün özeti:

Visual Identification: White to off-white, round, biconvex film coated tablet debossed with A40 on one side, and cross scored breaking notch on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 16 Months; Container Temperature: Store below 30 degrees Celsius

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

2020-12-10